250mg/day if your research subject is being administered a liver toxic oral. If being used to help offset liver anomalies after a cycle of liver toxic orals or for some other reason that dosage can be doubled or tripled. UDCA is an excellent product for this purpose.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.